Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London 2019
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Download 2018 Feedback Form (Required for Credits)
Pre-conference Presentations
2018 Program
2018 Speaker List & Presentation Download
Speaker Videos
2018 Pre-Conference Workshops
2018 Exhibitors
2018 Peer Review Board Members
Delegate Information
2018 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
Past Conference Information
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  Past Speakers 2004
  Past Speakers Monte Carlo 2002
BSAAM's AACL Organizer
BSAAM Affiliates
AACL Supporters
HB Health
  Sun Chlorella

AACL 2011 Speaker

BirkmayerProfessor George Birkmayer MD PhD
Ph.D. in Biochemistry, University of Vienna, Austria
M.D. from the University of Munich,.
Since 1982 Professor for Medical Chemistry, University of Graz, Austria.
Guest Lecturer at Universities in New York, Philadelphia, Montreal
Since 1989 visiting Professor at the Universities of Beijing, Guangzhou and Xi’An (China). He is a Fellow of the American College of Nutrition and a number of international societies.Since 2005 President of the Int. Academy of Tumour Marker Oncology (IATMO), New York. Honorary President of the International Academy of Tumor Target Therapy Guangzhou Senior Medical Advisor of Food and Agriculture Security Committee Affiliated to S.A.V.E.

Professor George Birkmayer, M.D.,Ph.D, discovered the therapeutic effect of NADH (Coenzyme-1) and developed the stabilized orally absorbable form of NADH. Using this formulation he has treated thousands of patients suffering from Parkinson, Alzheimer, depression, CFS, cancer and diabetes. He is the author of more than 150 scientific publications and a member of the editorial board of a number of scientific journals.

2011 - NADH (Coenzyme 1): Newest findings on its Anti-Diabetic, Anti-Obesity, Anti-Skin Aging and Ati-Fatigue Effect

Coenzyme-1 (N.A.D.H.) is one of the most important coenzyme catalyzing more than a thousand of metabolic reactions in the human body, the most important of which is the production of ATP (Adenosin-Tri-Phosphate) The more ATP energy a cell has available the better it can function and the longer it can live. The question is can we increase the ATP production in the cells by exposing them to coenzyme-1 (NADH). The answer is yes, we can, as has been shown on isolated heart cells. When hearts cells are incubated with NADH a 30% increase in ATP production is observed (1). Due to this the vitality and lifespan of these heart cells are increased.
This heart cell system allows to test other coenzymes and substances for which an energy increasing effect has been claimed. From all the substances tested so far including NAD (the oxidized form of NADH), Nicotinamide (Vitamine B3), Coenzyme Q10, Creatine, Carnitine , Caffeine only NADH does increase ATP production in these cells. NADH as biological form of hydrogen is a very sensitive substance which degrades rapidly even in dry state when blended with lactose the most common ingredient of drugs. The author succeeded in stabilizing NADH and transposing it into a tablet form in which NADH is stable for at least 2 years. This formulation, patented world-wide is commercially available under the brand name CELLERGIE™ NADH.
Based on the patent protection of this product numerous GCP studies have been performed in the U.S. as well as in Europe. In an FDA approved double-blind placebo controlled study it was found that NADH leads to an improvement of certain cognitive functions in patients with Alzheimer dementia. (2) . Another FDA approved double blind study with patients suffering from CFS (Chronic Fatigue Syndrome) revealed more than 80 % of the patients were relieved from their fatigue after a 6 month treatment period with 10 mg NADH per day(2).A retrospective analysis of the change in bodyweight of the CFS patients showed a decrease of 5.5 lbs per month with a daily dose of 10 mg NADH. In a further open label trial obese subjects (BMI > 30) were taking 40 mg NADH per day over 3 months. The reduction in weight was in the range of 4.5 to 6.0 kg in between the 3 month trial period. All subjects observed a higher energy level and better physical performance after 1 month. In a further study patients suffering from Diabetes Typ-2 were taking 80 mg NADH per day for 3 months. The average HbA1c value of these subjects were in the range of 13.0 – 15.3. After a 3 months treatment period the HbA1c levels declined to 6.8 – 8.5. All the patients could omit their antidiabetic medications after the 3 months therapy with NADH. The author developed a skin serum on the basis of NADH. A study performed at the department of dermatology of the university of Freiburg (Germany) showed an remarkable anti-wrinkle effect . Aging spots on the palm back disappeared after a 3 months treatment period.
Furthermore the effect of NADH on cognitive performance was tested with healthy middle aged individuals after sleep deprivation for 24 hours at Cornell University(New York) Subjects taking 20 mg of NADH did not only better than the subjects taking placebo but did more than 3 times better than the same subjects at base line, after a full night sleep (4). In other words, NADH enhances cognitive performance in healthy individuals and due to its energy-increasing effect for the brain it may prevent MCI (Mild Cognitive Impairment) as well as Alzheimer dementia. of NADH.(3) The mechanism of action of NADH is based in all the studies described on the elevation of the intracellular ATP. A detailed description of all potential therapeutic applications of NADH is compiled in my book “NADH – the biological hydrogen- the secret of our life energy (4).

(1) Pelzmann, B., et al., Brit.J.Pharm.2003, 139, 749-754
(2) ) Forsyth, L.M., et al. Ann.Allergy Asthma Immun. 1999, 82, 185-191
(3) Moline, ML. Et al. Abstr.1st Int. Conf. Mech. Action Nutraceuticals 2001
(4) Birkmayer G., Basic Health Publications Inc. CA 92651 (2009) ISBN 978-1-59120-262-2


Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :